vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36.75	9.45	12.13	13.42	5.75
Short-Term Investments	0.09	0.07	0.02	0.1	0.37
Cash & Short-Term Investments	36.83	9.51	12.14	13.52	6.12
Cash Growth	287.25%	-21.66%	-10.17%	120.91%	201.83%
Accounts Receivable	0.06	0.1	0.17	0.06	0.16
Other Receivables	-	-	-	0.14	-
Receivables	0.06	0.1	12.42	0.19	0.16
Prepaid Expenses	1.22	1.04	2.54	1.91	0.94
Total Current Assets	38.11	10.66	27.09	15.62	7.22
Property, Plant & Equipment	0.15	0.36	0.56	0.68	0.85
Long-Term Investments	-	-	5.59	9.17	6.73
Total Assets	38.27	11.02	33.24	25.47	14.79
Accounts Payable	0.94	4.08	2.46	1.88	1.93
Accrued Expenses	4.09	6.17	4.85	6.15	4.2
Short-Term Debt	-	0.19	0.22	0.26	0.08
Current Portion of Leases	0.17	0.17	0.15	0.18	0.16
Current Unearned Revenue	-	0.02	0.02	0.04	0.03
Total Current Liabilities	5.2	10.62	7.71	8.5	6.39
Long-Term Leases	-	0.17	0.34	0.49	0.68
Long-Term Unearned Revenue	18.67	18.67	18.67	-	1.01
Other Long-Term Liabilities	0.1	0.11	0.68	1.26	2.92
Total Liabilities	23.97	29.57	27.4	10.25	11
Common Stock	0.03	0.03	0.03	0.9	0.77
Additional Paid-In Capital	311.89	256.34	254.76	238.19	209.16
Retained Earnings	-299.72	-281.04	-265.52	-248.83	-290.04
Total Common Equity	12.2	-24.68	-10.74	-9.74	-80.1
Minority Interest	2.1	6.13	16.58	24.96	83.9
Shareholders' Equity	14.3	-18.55	5.84	15.22	3.79
Total Liabilities & Equity	38.27	11.02	33.24	25.47	14.79
Total Debt	0.17	0.53	0.72	0.93	0.92
Net Cash (Debt)	36.66	8.98	11.43	12.58	5.2
Net Cash Growth	308.17%	-21.38%	-9.20%	141.84%	-
Net Cash Per Share	6.35	4.31	5.95	8.03	4.42
Filing Date Shares Outstanding	2.61	2.43	2.04	1.67	1.44
Total Common Shares Outstanding	2.61	2.08	2.04	1.67	1.35
Working Capital	32.92	0.04	19.39	7.12	0.83
Book Value Per Share	4.67	-11.84	-5.27	-5.82	-59.28
Tangible Book Value	12.2	-24.68	-10.74	-9.74	-80.1
Tangible Book Value Per Share	4.67	-11.84	-5.27	-5.82	-59.28
Machinery	0.12	0.12	0.12	0.1	0.1
Leasehold Improvements	0.41	0.41	0.41	0.41	0.41

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q